RNAi Agents for Inhibiting Expression of Mitochondrial Amidoxime Reducing Component 1 (MARC1), Pharmaceutical Compositions Thereof, and Methods of Use
US-2026009037-A1 · Jan 8, 2026 · US
Braas Daniel is listed as an inventor on 9 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Braas Daniel |
| Total patents | 9 |
| First publication | Jan 5, 2023 |
| Latest publication | Jan 8, 2026 |
Publications ranked by popularity score, then publication date.
US-2026009037-A1 · Jan 8, 2026 · US
US-12503696-B2 · Dec 23, 2025 · US
US-2025075214-A1 · Mar 6, 2025 · US
US-2023139166-A1 · May 4, 2023 · US
US-2023125671-A1 · Apr 27, 2023 · US
US-11629349-B2 · Apr 18, 2023 · US
US-2023013224-A1 · Jan 19, 2023 · US
US-11549112-B1 · Jan 10, 2023 · US
US-2023002773-A1 · Jan 5, 2023 · US
Latest publications not already listed above.
No data yet.
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Arrowhead Pharmaceuticals Inc | 9 |
Most common classification codes across this inventor's patents.
| CPC | Patents |
|---|---|
| C12N2310/351 | 9 |
| C12N2310/321 | 9 |
| C12N2310/315 | 9 |
| C12N2310/14 | 9 |
| C12N2310/322 | 9 |